Brief: Ligand Reports First Quarter 2022 Financial Results

OmniAB

04/05/2022 22:57

May 4 (Reuters) - Ligand Pharmaceuticals Inc  LGND.O :
    * LIGAND REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
    * Q1 ADJUSTED EARNINGS PER SHARE $0.76
    * Q1 LOSS PER SHARE $0.91
    * Q1 REVENUE $45.7 MILLION
    * Q1 EARNINGS PER SHARE VIEW $0.66, REVENUE VIEW $36.3
MILLION --
REFINITIV IBES DATA
    * REAFFIRMING 2022 REVENUE GUIDANCE FOR COMBINED BUSINESS

Source text for Eikon:  ID:nBw63DBK0a 
Further company coverage:  LGND.O 

 ((Reuters.Briefs@thomsonreuters.com;))